Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2060-2070
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2060
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2060
Figure 1 Expression values of hsa-miR-29c in samples of normal gastric mucosa, non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type gastric adenocarcinoma, respectively (values in log scale).
P values were obtained by ANOVA test (adjusted by using Bonferroni’s correction).
- Citation: Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S, Ribeiro-dos-Santos Â. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 2016; 22(6): 2060-2070
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2060.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2060